Níveis séricos periféricos e mesentéricos de CEA e CA 242, estadiamento e variáveis histopatológicas no adenocarcinoma colorretal by Cardoso, Mauro Lamelas et al.
405  -  Acta Cirúrgica Brasileira - Vol. 24 (5) 2009
12 – ORIGINAL ARTICLE
Oncology
Relationship between peripheral and mesenteric serum levels of CEA and CA 242 with
staging and histopathological variables in colorectal adenocarcinoma1
Níveis séricos periféricos e mesentéricos de CEA e CA 242, estadiamento e variáveis
histopatológicas no adenocarcinoma colorretal
Mauro Lamelas CardosoI, Luís Cesar FernandesII, Su Bong KimIII, Delcio MatosIV
I Master, Gastroenterology Surgery, UNIFESP, Sao Paulo, Brazil.
II Affiliate Professor, Surgical Gastroenterology, Department of Surgery, School of Medicine, UNIFESP, Sao Paulo, Brazil.
III Affiliate Professor, Surgical Gastroenterology, Department of Surgery, School of Medicine, UNIFESP, Sao Paulo, Brazil.
IV Full Professor, Surgical Gastroenterology, Department of Surgery and Dean of Postgraduate Program of Surgical Gastroenterology, School of
Medicine, UNIFESP, Sao Paulo, Brazil.
ABSTRACT
Purpose: To compare histopathological variables and staging in colorectal adenocarcinoma cases with CEA and CA 242 in peripheral
and mesenteric blood. Methods: In 169 individuals underwent surgery for colorectal cancer, CEA and CA 242 were analyzed
and compared to mesenteric and peripheral blood and correlated with macroscopic tumor’s morphology and size, degree of cell
differentiation, venous, neural and lymphatic involvement and TNM classification. Results: There was a difference between the
mesenteric (M) and peripheral (P) serum levels of CEA (p=0.020). Higher levels of markers were correlated with venous invasion CEA
(P) p=0.013, CEA (M) p=0.05, CA 242 (M) p=0.005 and CA 242 (P) p=0.038; with advanced staging CEA (P) < CEA (M) (p < 0.05); CA
242 (P) < CA 242 (M) (p < 0.05); and with greater dimensions CEA (P) < CEA (M) (p < 0.001); CA 242 (P) < CA 242 (M) (p < 0.001).
CA 242 became higher with neural invasion (P): p=0.014, (M): p=0.003). Conclusions: There were higher mesenteric than peripheral
levels of CEA. Both mesenteric and peripheral levels of CEA and CA 242 were higher in neoplasm with venous involvement, greater
diameter and advanced stages. There was a correlation between CA 242 and neural invasion.
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RESUMO
Objetivo: Comparar variáveis histopatológicas e graus de estadiamento do adenocarcinoma colorretal com níveis sanguíneos periféricos
e mesentéricos de CEA e CA-242. Métodos: Em 169 doentes submetidos ao tratamento cirúrgico por adenocarcinoma colorretal,
CEA e CA-242 foram analisados e comparados quanto aos níveis sanguíneos periféricos e mesentéricos e correlacionados com o
tamanho e a morfologia macroscópica do tumor, grau de diferenciação celular, invasões venosa, linfática, neural e a classificação TNM.
Resultados: Verificou-se diferença significante entre o nível sérico mesentérico e periférico de CEA (p= 0,02). Níveis séricos mais
elevados dos marcadores foram observados e correlacionados com invasão venosa, CEA (P) p=0,013, CEA(M), p=0,05, CA-242 (M)
p=0,005 e CA-242 (P) p=0,038. Grau de estadiamento TNM avançado foi associado com CEA(P) < CEA(M) p<0,05, CA-242(P) <
CA-242(M) p<0,05. Nas maiores dimensões tumorais constatou-se CEA(P) < CEA(M) p=0,001 e CA 242 (P) < CA 242 (M) (p < 0.001).
O CA 242 periférico e mesentérico aumentados associaram-se com a invasão neural, p=0.014 e p=0.003, respectivamente.
Conclusões: O nível sérico mesentérico de CEA é superior ao nível sérico periférico. Os níveis séricos mesentéricos e periféricos do
CEA e do CA-242 são mais elevados no adenocarcinoma com invasão venosa, de maior diâmetro e de estadios avançados. Existe uma
associação entre o nível sérico do Ca-242 e a invasão neural.
Descritores: Adenocarcinoma. Prognóstico. Marcadores Biológicos de Tumor. Colo. Reto.
1Research performed at Coloproctology Unit, Division of Surgical Gastroenterology, Department of Surgery, Federal University of Sao Paulo UNIFESP),
Brazil.
Introduction
Colorectal cancer is the third most common cause of
cancer worldwide in both sexes and the second cause in developed
countries. Geographical patterns are similar between men and
women; however, rectal cancer is around 20-50% higher in men in
the majority of populations1.
The estimated number of new cases of colorectal cancer
in Brazil for the year 2008 is 12,490 in men and 14,500 in women,
corresponding to an estimated risk of 13 new cases per 100,000
men and 15 per 100,000 women1. The greatest incidence is in the
age group between 50 and 70 years old, and it may develop from
the age of 40 onwards.
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Survival is considered good with this type of cancer if
the disease is diagnosed at an early stage. Global mean 5-year
survival rates vary from 40 to 50% and no great differences are
found between developed and developing countries1. Attempts
have been made to develop more efficient tracking methods and
identify prognostic factors that could assist in the administration
of more aggressive therapy in selected cases2.
Tumor markers are substances present in tumor, blood or
other biological fluids that are produced by patients or by
neoplastic cells. They can be used for screening, for diagnosis,
for establishing prognosis, for monitoring treatment, and for
detecting relapse3.
One of the markers of great use for colorectal neoplasia
is carcinoembryonic antigen (CEA), which was described by Gold
& Freedman4 in 1965. CEA is not specific for colorectal cancer,
and can present high levels in non-malignant clinical situations
(pancreatitis, perforated ulcers, liver cirrhosis and smoking) and in
malignant situation in other organs (stomach, lungs and ovaries)5.
However, it remains the best marker for colorectal neoplasia6.
Other markers have emerged: cytokeratins (TPA) and cell
membrane glycoproteins (CA 19-9, CA 242 and CA 72-4)6.
Like CEA, the preoperative levels of CA 242 may have their
importance in determining survival, just as postoperative assaying
may assist in determining recurrences of colorectal cancer7.
The correlation between the tumor marker levels in
the peripheral and mesenteric blood is controversial8. Blood
collection directly from the drainage veins of the colorectal tumor
could predict metastasis to the liver. Some authors have observed
significantly higher levels of CEA in the mesenteric blood9,10, while
others have not observed any significant difference11.
Comparisons between the CA 242 and CEA levels in the
peripheral and mesenteric blood and their correlations with
disease staging and histopathological variables have not yet been
completely clarified in the literature. Because these correlations
are important for better comprehension of these tumor markers
and consequently for obtaining progress in treatments for patients,
they comprise the objective of the present investigation.
Methods
This was a retrospective study of the medical records
and database of the Coloproctology Group, Discipline of Surgical
Gastroenterology, Department of Surgery, Federal University of
Sao Paulo - School of Medicine (UNIFESP – EPM), at Sao Paulo’s
Hospital. The studied sample was 169 patients with colorectal
adenocarcinoma who underwent surgical intervention between
March 1993 and December 2000, attended consecutively. The
present research was approved by the institutional ethics committee.
Patients were not included in the study if they had a
previous history of other neoplasias (whether benign or malignant);
if they did not agree with the experiment; or if they were not
available for periodic postoperative clinical follow-up.
Ninety-six patients (56.8%) were women. The patients’ ages
ranged from 19 to 89 years, with a mean of 62.2 years (standard
deviation (SD) = 13.2). One hundred and sixteen patients were
white (69.2%), 13 (7.7%) were yellow, 5 (3.0%) were black and 34
(20.1%) were brown. With regard to location, 39 patients (23.1%)
presented neoplasia in the right colon, 6 (3.6%) in the transverse
colon, 32 (18.9%) in the left colon and 92 (54.4%) in the rectum.
Amongst 169 patients, resection of the neoplasia was
possible in 154 cases. Following surgical removal of the tumor, the
material was fixed in formol, labeled and sent to the Pathological
Anatomy Laboratory of Sao Paulo’s Hospital – School of
Medicine, where it was analyzed.
One hundred and twenty patients (77.9%) presented
ulcerated tumor lesions, 76 (49.4%) vegetating lesions and 70
(45.4%) infiltrating lesions (several patients presented mixed types
of lesions). Analysis under the microscope showed that 25 patients
(17.2%) presented signs of venous invasion, 48 (31.2%) lymphatic
invasion and 40 (26.0%) neural invasion. The mean diameter of
tumor lesions was 6.1 cm (SD = 2.7 cm). Sixty-five patients (42.2%)
presented well-differentiated tumors, 86 (55.9%) moderately
differentiated tumors, three (2.0%) poorly differentiated tumors
and there were no cases of undifferentiated tumors. TNM system
was used for staging.
Peripheral blood was collected by venous puncture in
the arm that was not being used for infusion of substances or
hydration while anesthesia was being induced. The serum was
separated by centrifugation and stored at –20°C.
Mesenteric blood was collected by catheterization of
the tributary vein corresponding to the site of colorectal
adenocarcinoma that was being resected: for tumors in the left colon
and rectum, the inferior mesenteric vein; for tumors in the transverse
colon, the middle colic vein; and for tumors in the right colon, the
corresponding wide tributary vein and finishing in the superior
mesenteric vein. This procedure was performed before any
manipulation of the tumor, and the samples were processed and
stored at the same way that those obtained from the peripheral blood.
The markers were assayed in the Clinical Analyses
Laboratory of Sao Paulo’s Hospital. To quantify CEA
(carcinoembryonic antigen), the Delfia® method, based on
immunofluorescence, was used, and values less than 5 ng/ml
were considered normal8. The assaying of CA 242 was performed
by the immunoenzymatic method (EIE). Expression of up to 20
U/ml was considered normal7,8.
The statistical analyze was performed by descriptive
analysis of the data, using summary measurements. The inferential
analysis consisted of two situations: association between the markers
and a categorical variable and association between the markers and
a numerical variable. For the first case, Fisher’s exact test was used,
and Student’s t test for unrelated samples was applied for the
second one. For calculation purposes, the data were transformed
into logarithms. Statistical differences with a level of 0.05 or 5%
(Į < 0.05) were considered significant.
Results
Comparison between the peripheral and mesenteric serum
levels of the tumor markers demonstrated that the measurements
differed for CEA (P): 23.88 ng/ml ± 95.46 ng/ml; (M): 39,10 ng/ml
± 121.19 ng/ml (p=0.020) but not for CA 242 (P): 89.53 U/ml ±
397.73 U/ml, (M): 94.88 U/ml ± 404.79 U/ml (p = 0.42).
Correlating the tumor markers and the macroscopic
morphology of lesions, no statistical association was found.
High levels of markers correlate with venous invasion:
Patients who had vessel invasion, in pathological analyzes, showed
high levels of CEA (M) in 60.9%. Those who had not venous
invasion showed 37.6% of abnormal values (p=0,05). In the same
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way, CEA (P) level was increased in 64% of patients with venous
invasion, and elevated in 37.7% without vessel involvement
(p=0.013). CA 242 (M) was increased in 56.5% of patients who
had venous invasion and elevated in 25% of patients without venous
invasion (p= 0.005). Patients with venous involvement by tumor
had 47.8% of high levels of CA 242 (P) detected, whereas 24% of
the patients without venous invasion also had this high marker
level (p=0,038) (Table 1).




  VENOUS INVASION  
  NO YES p 
MESENTERIC 
CEA 
NORMAL LEVEL  63 (62.4%) 9 (39.1%) 
0.050* HIGH LEVEL  38 (37.6%) 14 (60.9%) 
TOTAL PATIENTS  101  23 
PERIPHERIC 
CEA 
NORMAL LEVEL 83 (64.3%) 9 (36%) 
0.013* HIGH LEVEL 46 (37.7%) 16 (64%) 
TOTAL PATIENTS  129 25 
MESENTERIC 
CA 242 
NORMAL LEVEL 75 (75%) 10 (43.5%) 
0.005* HIGH LEVEL 25 (25%) 13 (56,5%) 
TOTAL PATIENTS  100 23 
PERIPHERIC 
CA 242 
NORMAL LEVEL 76 (76%) 12 (52,2%) 
0.038* HIGH LEVEL 24 (24%) 11 (47,8%) 
TOTAL PATIENTS  100 23 
Regarding to neural invasion, more abnormal values of
CA 242 were found.  In peripheral blood, 22.2% patients had high
CA 242 levels and no neural invasion and 47.8% had high levels,
but neural invasion was established (p=0.014); in mesenteric blood,
TABLE 2 – Correlation between markers and neural invasion
 
 
  NEURAL INVASION  
  NO YES p 
MESENTERIC 
CEA 
NORMAL LEVEL  55 (60.5%) 17 (51.5%) 
0,414 HIGH LEVEL  36 (39.5%) 16 (48.5%) 
TOTAL PATIENTS  91  33 
PERIPHERIC 
CEA 
NORMAL LEVEL 70 (61.4%) 22 (55%) 
0,574 HIGH LEVEL 44 (38.6%) 18 (45%) 
TOTAL PATIENTS  114 40 
MESENTERIC 
CA 242 
NORMAL LEVEL 69 (76,7%) 16 (48.8%) 
0,003* HIGH LEVEL 21 (23.3%) 17 (51,5%) 
TOTAL PATIENTS  90 33 
PERIPHERIC 
CA 242 
NORMAL LEVEL 70 (77,8%) 18 (52,2%) 
0,014* HIGH LEVEL 20 (22.2%) 15(47,8%) 
TOTAL PATIENTS  90 33 
23.3% and 51.5% of abnormal levels were found, in the absence
and in the presence of neural invasion, respectively (p=0.003). No
significant statistical differences were detected in CEA levels (P)
p=0.574 and (M) p=0.414 (Table 2).
TABLE 1 – Correlation between markers and venous invasion
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Correlating the markers with the tumor diameter,
mesenteric and peripheral CEA and CA 242 showed a direct
association with the tumor diameter (Table 3).
Comparing the degree of cell differentiation with the
levels of markers, no significant statistical relationship was shown.
SD: standard deviation
TABLE 3 - Correlation between markers and tumor size
  TUMOR SIZE (cm)  
  MEAN SD p 
MESENTERIC 
CEA 
NORMAL LEVEL  5.75 2.45 
0,035* 
HIGH LEVEL 6.37 2.82 
PERIPHERIC 
CEA 
NORMAL LEVEL 5.49 2.37 
0,001* 
HIGH LEVEL 6.95 2.84 
MESENTERIC 
CA 242 
NORMAL LEVEL 5.77 2.52 
0,011* 
HIGH LEVEL 6.46 2.80 
PERIPHERIC 
CA 242 
NORMAL LEVEL 5.78 2.48 
0,008* HIGH LEVEL 6.48 2.86 
   
Considering the TNM classification, both markers presented significant correlations with staging (Table 4).
TABLE 4 – Difference between mesenteric and peripheral marker’s levels
P = peripheral
M = mesenteric
 Stage I Stage II Stage III Stage IV  
CEA P (ng/ml) 14.2 ± 48.5 8.5 ± 29.3 8.0 ± 15.5 87.7 ± 187.8 p < 0.05 
CEA M (ng/ml) 15.0 ± 43.0 3.7 ± 3.2  11.3 ± 21.2  90.3 ± 190.1 
CA 242 P (U/ml) 9.0 ± 10.3  15.7 ± 16.4 26.1 ± 38.4  219.1 ± 650.8 p < 0.05 
CA 242 M (U/ml) 9.5 ± 11.9  16.8 ± 18.2 28.4 ± 38.7 227.8 ± 661.2 
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Discussion
The success in treating the cancer disease directly depends
the stage when the diagnosis is made. Thus, it is fundamentally
important to recognize the neoplasm at an early stage. The most
important objective of researching serological markers and their
correlation with histopathological variables is to identify factors
that could be correlated to the prognosis of the disease.
The increased CEA levels in the mesenteric serum, and
their relation to the peripheral serum, are compatible with the
findings of Tabuchi et al.9,10, who suggested that the drainage of
CEA takes place mainly via the portal system. In the present
investigation, this situation was corroborated, which makes it
possible to put forward the same hypothesis. Measurement of this
marker in the mesenteric blood could increase the sensitivity of
the method in relation to the conventional one and could perhaps
allow to predict which cases could present extra-colonic disease,
hepatic micrometastasis, and which ones could be potential
candidates for more aggressive therapeutic schemes, that could
increase time and quality of life. Regarding to CA 242, there was
no significant statistical difference between the levels found at
the two sites, but this marker seems to be as useful as CEA for
assaying in mesenteric blood.
Comparing tumor markers with lesion morphology, no
significant statistical difference were detected between vegetating,
ulcerated or infiltrative tumors. The macroscopic aspect did not
show any correlation with normal and abnormal values of these
two markers.
The importance of neural, lymphatic and vascular
invasion on survival and on the prognosis for colorectal cancer
has already been the topic of many researches in the literature2,12,
and it has been shown that the involvement of these structures is
associated with worse prognosis.
The studies by Tabuchi et al.9,10 showed higher levels of
mesenteric and peripheral CEA  correlated with venous invasion.
In the present study, like them, higher peripheral and mesenteric
levels of CEA were found in patients with colorectal adenocarcinoma
with venous invasion.
A statistical association with venous system invasion
was also found CA 242, both in peripheral than mesenteric blood
assays. This emphasizes the importance of this marker and opens
up the possibility of developing new studies that correlate this
marker with survival and staging. It may suggest that the drainage
route for this marker is preponderantly hematogenic, via the
mesenteric-portal system.
Tabuchi et al.10 were able to demonstrate an association
between mesenteric CEA levels and the presence of lymphatic
invasion, which was not confirmed in the present investigation.
Regarding to neural involvement, the marker CA 242 in
mesenteric and peripheral serum showed to be better than CEA to
predict the invasion of these structures.
Evaluating the prognostic factors for colorectal cancer in
the consensus of the College of American Pathologists, Compton
et al.13 considered that the tumor dimensions measured after
surgical remove were a variable of low interest regarding the
evolution of the disease. Measurement of the tumor diameter and
its correlation with normal or abnormal levels of tumor markers
has the objective of identifying which ones are related to earlier
or later neoplastic lesions. Studies have shown that peripheral
and mesenteric CEA levels are higher when associated with larger
lesions10. It is suggested that with greater volumes of neoplastic
cells, the quantity of the tumor marker produced and released into
the circulation ought to be greater.
Comparing the groups of patients with normal and
abnormal levels of CEA and CA 242 (assayed in the peripheral and
mesenteric serum) with the TNM staging, both of these markers
showed statistical significance for this variable.
Forones et al.14 retrospectively studied peripheral CEA
levels in 83 patients with regard to prognoses for colorectal cancer
and correlated these with the Dukes staging. They found that CEA
had a capacity to differentiate stage A from stage C and C from B,
but not A from B. In another study on 240 patients with colorectal
cancer15, the same authors were able, by the increased CEA levels,
to differentiate the patients in stage B from stage D and C from D,
but not those in B from C.
In the present investigation, this power of discrimination
was not attained. However, stages I, II and III of the TNM
classification were clearly differentiated from stage IV. It is believed
that, in cases of extra-colonic disease, with extension to adjacent
and distant organs and structures, a significant increase in the
production and release of tumor markers takes place.
It is known that tumors with less differentiation are
associated with worse prognosis for recurrence and survival13.
Other studies, however, have not found significant statistical
correspondence for this variable12. In the present study, it was not
possible to identify any relationship between the markers and the
degree of cell differentiation of the tumors. This requires new studies
and investigations.
The ideal marker does not exist yet, but attempts continue
towards obtaining better comprehension of the metabolism of the
existing markers, with the aim of optimizing their utilization and
consequently improving the medical supervision of patients with
colorectal adenocarcinoma16,17.
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